NOVA EYE MEDICAL LIMITED - Announcements

0.00%

14.0¢

Market Cap $39.85M

Technology Scientific & Technical Instruments

Nova Eye Medical Limited is an Australia-based medical technology company that develops,... Nova Eye Medical Limited is an Australia-based medical technology company that develops, manufactures, and sells a portfolio of proprietary ophthalmic treatment technologies and devices. The Company operates through three segments: AlphaRET, and Glaucoma surgical devices. The Company’s AlphaRET segment is responsible for the commercialization of the 2RT ophthalmic laser, which is an ophthalmic laser developed for the therapy of patients in the early to intermediate stages of age-related macular degeneration (AMD). 2RT is a patented nano-pulse laser device that rejuvenates retinal structures compromised by AMD. The Glaucoma Surgical Devices segment includes the designing, manufacturing, marketing, and sale of the iTrack, iTrack Advance and the Molteno3 glaucoma surgical device. The Molteno3 glaucoma drainage device platform is designed to enhance surgical utility and optimize clinical outcomes for long-term intraocular pressure (IOP) control in cases of severe glaucoma.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

Announcements

Filter Results

All Price Sensitive Only

EYE	Amended Appendix 3B		09/12/16	206.3KB	Share
EYE	Cleansing Statement		09/12/16	183.25KB	Share
EYE	Appendix 3B		09/12/16	198.16KB	Share
EYE	Ellex raises $10.3 million	PRICE SENSITIVE	01/12/16	38.85KB	Share
EYE	Trading Halt	PRICE SENSITIVE	30/11/16	121.32KB	Share
EYE	Results of Meeting		23/11/16	22.17KB	Share
EYE	2016 CEO's AGM Presentation		23/11/16	1.84MB	Share
EYE	2016 AGM Script		23/11/16	166.31KB	Share
EYE	ELX announces iTrack USA Reimbursement Increase	PRICE SENSITIVE	10/11/16	107.71KB	Share
EYE	Notice of Annual General Meeting-ELX.AX		21/10/16	155.42KB	Share
EYE	Annual Report to shareholders-ELX.AX		21/10/16	4.97MB	Share
EYE	Change of Director's Interest Notice-ELX.AX		17/10/16	226.36KB	Share
EYE	Change in substantial holding from AEF,AEF-ELX.AX		07/10/16	449.69KB	Share
EYE	Change of Director's Interest Notice-ELX.AX		05/10/16	226.17KB	Share
EYE	Appendix 4G-ELX.AX		03/10/16	258.29KB	Share
EYE	Corporate Governance Statement-ELX.AX		03/10/16	302.01KB	Share
EYE	Ellex Announces Launch of New Ophthalmic Ultrasound Device-ELX.AX	PRICE SENSITIVE	06/09/16	65.23KB	Share
EYE	Ellex Investor Presentation Y16 Results-ELX.AX		29/08/16	695.41KB	Share
EYE	Ellex announces FY Results for 2016-ELX.AX		29/08/16	32.89KB	Share
EYE	Ellex - Appendix 4E & Full Year Statutory Accounts 2016-ELX.AX	PRICE SENSITIVE	29/08/16	5.03MB	Share
EYE	Ellex awarded $2.5m Federal Government Grant-ELX.AX	PRICE SENSITIVE	28/08/16	26.48KB	Share
EYE	Ellex awarded $2.5m Federal Government Grant-ELX.AX	PRICE SENSITIVE	26/08/16	26.48KB	Share
EYE	Trading Update for Full Year Ended 30 June 2016-ELX.AX	PRICE SENSITIVE	28/07/16	430.31KB	Share
EYE	Change in substantial holding from AEF,AEF-ELX.AX		19/07/16		Share
EYE	Change in substantial holding from AEF,AEF-ELX.AX		19/07/16	443.81KB	Share
EYE	China FDA Approval for Ophthalmic Treatment Lasers-ELX.AX	PRICE SENSITIVE	15/06/16	29.24KB	Share
EYE	Change of Director's Interest Notice-ELX.AX		06/06/16	226.52KB	Share
EYE	Ellex Announces Interim Review for 2RT Clinical Trial-ELX.AX	PRICE SENSITIVE	30/05/16	30.79KB	Share
EYE	Ellex Announces Positive iTrack 12-Month Data-ELX.AX	PRICE SENSITIVE	06/05/16	35.61KB	Share
EYE	Change in Substantial Holding from AEF,AEF-ELX.AX		15/04/16	374.35KB	Share
EYE	Appendix 3B-ELX.AX		13/04/16	206.12KB	Share
EYE	Cleansing Notice-ELX.AX		13/04/16	85.66KB	Share
EYE	Ellex raises $5 million-ELX.AX	PRICE SENSITIVE	07/04/16	23.31KB	Share
EYE	Trading Halt-ELX.AX	PRICE SENSITIVE	06/04/16	241.7KB	Share
EYE	Change in substantial holding from AEF - correction		16/03/16	403.43KB	Share
EYE	Change in Substantial Holding from AEF		14/03/16	371.7KB	Share
EYE	ELX 1H FY16 ASX Release and Investor Presentation		26/02/16	777.79KB	Share
EYE	Half Yearly Report and Accounts	PRICE SENSITIVE	26/02/16	463.63KB	Share
EYE	Trading Update for Half-Year Ended 31 December 2015	PRICE SENSITIVE	29/01/16	593.01KB	Share
EYE	ELX expands production facilities to meet demand	PRICE SENSITIVE	22/01/16	23.64KB	Share
EYE	Change in Substantial Holding from AEF		11/01/16	112.5KB	Share
EYE	Ellex provides a Summary of ABiC iTrack Opportunity	PRICE SENSITIVE	04/12/15	44.25KB	Share
EYE	Results of Meeting		25/11/15	30.17KB	Share
EYE	2015 CEO's AGM Presentation		25/11/15	1.45MB	Share
EYE	2015 AGM Script		25/11/15	45.8KB	Share
EYE	ELX iTrack Achieves Further Market Traction		04/11/15	42.11KB	Share
EYE	Notice of Annual General Meeting/Proxy Form		23/10/15	1002.88KB	Share
EYE	ELX Sales Strategy Yields Positive Results in First Quarter	PRICE SENSITIVE	08/10/15	401.58KB	Share
EYE	Ellex Market Expansion into MIGS	PRICE SENSITIVE	01/10/15	402.72KB	Share
EYE	Corporate Governance Statement		30/09/15	83.87KB	Share
EYE	Appendix 4G		29/09/15	257.45KB	Share
EYE	Annual Report to shareholders		29/09/15	1.68MB	Share
EYE	Ellex releases first case study results for 2RT at tradeshow	PRICE SENSITIVE	14/09/15	717.75KB	Share
EYE	ELX Investor Presentation FY15 Results		27/08/15	2.01MB	Share
EYE	Ellex Report Full Year 2015 Preliminary Report Appendix 4E		27/08/15	26.77KB	Share
EYE	ELX Preliminary Financial Report Appendix 4E FY15	PRICE SENSITIVE	27/08/15	600.63KB	Share
EYE	Trading Update for the Full Year Ended 30 June 2015	PRICE SENSITIVE	30/07/15	432.56KB	Share
EYE	2RT Grant Awarded, Commercial Update	PRICE SENSITIVE	14/07/15	33KB	Share
EYE	More Scientific Research Validates Clinical Effect of 2RT	PRICE SENSITIVE	19/05/15	26.65KB	Share
EYE	Ellex lifts Global Market Share		06/05/15	28.92KB	Share
EYE	Ellex attending major tradeshow in China		30/03/15	25.69KB	Share
EYE	Investor Presentation H1FY15		27/02/15	1.51MB	Share
EYE	Half Yearly Results FY15		27/02/15	424.2KB	Share
EYE	Half Yearly Report and Accounts	PRICE SENSITIVE	27/02/15	552.28KB	Share
EYE	2RT Makes Headline in Peer-Review Publication		05/02/15	381.09KB	Share
EYE	Trading Update for the half-year ended 31 December 2014	PRICE SENSITIVE	29/01/15	29.29KB	Share
EYE	Results of Meeting		26/11/14	256.13KB	Share
EYE	Shareholder Update at AGM	PRICE SENSITIVE	26/11/14	27.87KB	Share
EYE	CEO's AGM Presentation		26/11/14	211.45KB	Share
EYE	Further positive clinical data on 2RT	PRICE SENSITIVE	18/11/14	32.77KB	Share
EYE	Change of Director's Interest Notice		12/11/14	226.19KB	Share
EYE	Change of Director's Interest Notice		10/11/14	226.24KB	Share
EYE	Change of Director's Interest Notice		10/11/14	194.48KB	Share
EYE	Canaloplasty Glaucoma Surgery Recognised as Gold Standard		29/10/14	568.39KB	Share
EYE	Notice of Annual General Meeting/Proxy Form		22/10/14	332.52KB	Share
EYE	Annual Report to Shareholders		22/10/14	1.04MB	Share
EYE	Ellex Investor Presentation 2014		23/09/14	551.73KB	Share
EYE	Ellex US Investor Presentation 2014		18/09/14	372.24KB	Share
EYE	Ellex - 2RT Laser Clinical Update at ESCRS		12/09/14	75.06KB	Share
EYE	Ellex announces Full-Year Results for FY2014		29/08/14	66.94KB	Share
EYE	Appendix 4E & Full-Year Statutory Accounts	PRICE SENSITIVE	29/08/14	772.11KB	Share
EYE	Trading Update FY14 Results	PRICE SENSITIVE	05/08/14	399.34KB	Share
EYE	Commercial Sales of 2RT Laser	PRICE SENSITIVE	08/07/14	488.7KB	Share
EYE	ELX announces further results for 2RT treatment of early AMD	PRICE SENSITIVE	15/05/14	85.46KB	Share
EYE	Investor Presentation for H1FY14		19/03/14	1.31MB	Share
EYE	Half Yearly Report and Accounts	PRICE SENSITIVE	27/02/14	665.29KB	Share
EYE	Ellex - CE Mark for 2RT Treatment of Early Stage AMD	PRICE SENSITIVE	24/02/14	73.23KB	Share
EYE	Trading Update for half-year ended 31 December 2013	PRICE SENSITIVE	30/01/14	63.59KB	Share
AEF +EYE	Change of substantial holder from AEF		07/01/14	82.85KB	Share
EYE	Ellex Completes Acquisition of Canaloplasty Business		06/01/14	604.29KB	Share
EYE	Appendix 3B		03/01/14	308.75KB	Share
EYE	Acquistion and Capital Raise	PRICE SENSITIVE	20/12/13	526.96KB	Share
EYE	Trading Halt	PRICE SENSITIVE	18/12/13	192.33KB	Share
EYE	Results of Meeting		28/11/13	284.69KB	Share
EYE	Ellex AGM Presentation		28/11/13	526.16KB	Share
EYE	ELX USA SLT Glaucoma Laser Update	PRICE SENSITIVE	12/11/13	69.5KB	Share
AEF +EYE	Change in substantial holding from AEF		01/11/13	81.93KB	Share
EYE	Notice of Annual General Meeting/Proxy Form		24/10/13	377.99KB	Share
EYE	Annual Report to shareholders		24/10/13	825.81KB	Share
EYE	Release of Positive Pilot Study Results for 2RT Treatment	PRICE SENSITIVE	14/10/13	77.82KB	Share

EYE Amended Appendix 3B
09/12/16		206.3KB	Share
EYE Cleansing Statement
09/12/16		183.25KB	Share
EYE Appendix 3B
09/12/16		198.16KB	Share
EYE Ellex raises $10.3 million
01/12/16	PRICE SENSITIVE	38.85KB	Share
EYE Trading Halt
30/11/16	PRICE SENSITIVE	121.32KB	Share
EYE Results of Meeting
23/11/16		22.17KB	Share
EYE 2016 CEO's AGM Presentation
23/11/16		1.84MB	Share
EYE 2016 AGM Script
23/11/16		166.31KB	Share
EYE ELX announces iTrack USA Reimbursement Increase
10/11/16	PRICE SENSITIVE	107.71KB	Share
EYE Notice of Annual General Meeting-ELX.AX
21/10/16		155.42KB	Share
EYE Annual Report to shareholders-ELX.AX
21/10/16		4.97MB	Share
EYE Change of Director's Interest Notice-ELX.AX
17/10/16		226.36KB	Share
EYE Change in substantial holding from AEF,AEF-ELX.AX
07/10/16		449.69KB	Share
EYE Change of Director's Interest Notice-ELX.AX
05/10/16		226.17KB	Share
EYE Appendix 4G-ELX.AX
03/10/16		258.29KB	Share
EYE Corporate Governance Statement-ELX.AX
03/10/16		302.01KB	Share
EYE Ellex Announces Launch of New Ophthalmic Ultrasound Device-ELX.AX
06/09/16	PRICE SENSITIVE	65.23KB	Share
EYE Ellex Investor Presentation Y16 Results-ELX.AX
29/08/16		695.41KB	Share
EYE Ellex announces FY Results for 2016-ELX.AX
29/08/16		32.89KB	Share
EYE Ellex - Appendix 4E & Full Year Statutory Accounts 2016-ELX.AX
29/08/16	PRICE SENSITIVE	5.03MB	Share
EYE Ellex awarded $2.5m Federal Government Grant-ELX.AX
28/08/16	PRICE SENSITIVE	26.48KB	Share
EYE Ellex awarded $2.5m Federal Government Grant-ELX.AX
26/08/16	PRICE SENSITIVE	26.48KB	Share
EYE Trading Update for Full Year Ended 30 June 2016-ELX.AX
28/07/16	PRICE SENSITIVE	430.31KB	Share
EYE Change in substantial holding from AEF,AEF-ELX.AX
19/07/16			Share
EYE Change in substantial holding from AEF,AEF-ELX.AX
19/07/16		443.81KB	Share
EYE China FDA Approval for Ophthalmic Treatment Lasers-ELX.AX
15/06/16	PRICE SENSITIVE	29.24KB	Share
EYE Change of Director's Interest Notice-ELX.AX
06/06/16		226.52KB	Share
EYE Ellex Announces Interim Review for 2RT Clinical Trial-ELX.AX
30/05/16	PRICE SENSITIVE	30.79KB	Share
EYE Ellex Announces Positive iTrack 12-Month Data-ELX.AX
06/05/16	PRICE SENSITIVE	35.61KB	Share
EYE Change in Substantial Holding from AEF,AEF-ELX.AX
15/04/16		374.35KB	Share
EYE Appendix 3B-ELX.AX
13/04/16		206.12KB	Share
EYE Cleansing Notice-ELX.AX
13/04/16		85.66KB	Share
EYE Ellex raises $5 million-ELX.AX
07/04/16	PRICE SENSITIVE	23.31KB	Share
EYE Trading Halt-ELX.AX
06/04/16	PRICE SENSITIVE	241.7KB	Share
EYE Change in substantial holding from AEF - correction
16/03/16		403.43KB	Share
EYE Change in Substantial Holding from AEF
14/03/16		371.7KB	Share
EYE ELX 1H FY16 ASX Release and Investor Presentation
26/02/16		777.79KB	Share
EYE Half Yearly Report and Accounts
26/02/16	PRICE SENSITIVE	463.63KB	Share
EYE Trading Update for Half-Year Ended 31 December 2015
29/01/16	PRICE SENSITIVE	593.01KB	Share
EYE ELX expands production facilities to meet demand
22/01/16	PRICE SENSITIVE	23.64KB	Share
EYE Change in Substantial Holding from AEF
11/01/16		112.5KB	Share
EYE Ellex provides a Summary of ABiC iTrack Opportunity
04/12/15	PRICE SENSITIVE	44.25KB	Share
EYE Results of Meeting
25/11/15		30.17KB	Share
EYE 2015 CEO's AGM Presentation
25/11/15		1.45MB	Share
EYE 2015 AGM Script
25/11/15		45.8KB	Share
EYE ELX iTrack Achieves Further Market Traction
04/11/15		42.11KB	Share
EYE Notice of Annual General Meeting/Proxy Form
23/10/15		1002.88KB	Share
EYE ELX Sales Strategy Yields Positive Results in First Quarter
08/10/15	PRICE SENSITIVE	401.58KB	Share
EYE Ellex Market Expansion into MIGS
01/10/15	PRICE SENSITIVE	402.72KB	Share
EYE Corporate Governance Statement
30/09/15		83.87KB	Share
EYE Appendix 4G
29/09/15		257.45KB	Share
EYE Annual Report to shareholders
29/09/15		1.68MB	Share
EYE Ellex releases first case study results for 2RT at tradeshow
14/09/15	PRICE SENSITIVE	717.75KB	Share
EYE ELX Investor Presentation FY15 Results
27/08/15		2.01MB	Share
EYE Ellex Report Full Year 2015 Preliminary Report Appendix 4E
27/08/15		26.77KB	Share
EYE ELX Preliminary Financial Report Appendix 4E FY15
27/08/15	PRICE SENSITIVE	600.63KB	Share
EYE Trading Update for the Full Year Ended 30 June 2015
30/07/15	PRICE SENSITIVE	432.56KB	Share
EYE 2RT Grant Awarded, Commercial Update
14/07/15	PRICE SENSITIVE	33KB	Share
EYE More Scientific Research Validates Clinical Effect of 2RT
19/05/15	PRICE SENSITIVE	26.65KB	Share
EYE Ellex lifts Global Market Share
06/05/15		28.92KB	Share
EYE Ellex attending major tradeshow in China
30/03/15		25.69KB	Share
EYE Investor Presentation H1FY15
27/02/15		1.51MB	Share
EYE Half Yearly Results FY15
27/02/15		424.2KB	Share
EYE Half Yearly Report and Accounts
27/02/15	PRICE SENSITIVE	552.28KB	Share
EYE 2RT Makes Headline in Peer-Review Publication
05/02/15		381.09KB	Share
EYE Trading Update for the half-year ended 31 December 2014
29/01/15	PRICE SENSITIVE	29.29KB	Share
EYE Results of Meeting
26/11/14		256.13KB	Share
EYE Shareholder Update at AGM
26/11/14	PRICE SENSITIVE	27.87KB	Share
EYE CEO's AGM Presentation
26/11/14		211.45KB	Share
EYE Further positive clinical data on 2RT
18/11/14	PRICE SENSITIVE	32.77KB	Share
EYE Change of Director's Interest Notice
12/11/14		226.19KB	Share
EYE Change of Director's Interest Notice
10/11/14		226.24KB	Share
EYE Change of Director's Interest Notice
10/11/14		194.48KB	Share
EYE Canaloplasty Glaucoma Surgery Recognised as Gold Standard
29/10/14		568.39KB	Share
EYE Notice of Annual General Meeting/Proxy Form
22/10/14		332.52KB	Share
EYE Annual Report to Shareholders
22/10/14		1.04MB	Share
EYE Ellex Investor Presentation 2014
23/09/14		551.73KB	Share
EYE Ellex US Investor Presentation 2014
18/09/14		372.24KB	Share
EYE Ellex - 2RT Laser Clinical Update at ESCRS
12/09/14		75.06KB	Share
EYE Ellex announces Full-Year Results for FY2014
29/08/14		66.94KB	Share
EYE Appendix 4E & Full-Year Statutory Accounts
29/08/14	PRICE SENSITIVE	772.11KB	Share
EYE Trading Update FY14 Results
05/08/14	PRICE SENSITIVE	399.34KB	Share
EYE Commercial Sales of 2RT Laser
08/07/14	PRICE SENSITIVE	488.7KB	Share
EYEELX announces further results for 2RT treatment of early AMD
15/05/14	PRICE SENSITIVE	85.46KB	Share
EYEInvestor Presentation for H1FY14
19/03/14		1.31MB	Share
EYEHalf Yearly Report and Accounts
27/02/14	PRICE SENSITIVE	665.29KB	Share
EYEEllex - CE Mark for 2RT Treatment of Early Stage AMD
24/02/14	PRICE SENSITIVE	73.23KB	Share
EYETrading Update for half-year ended 31 December 2013
30/01/14	PRICE SENSITIVE	63.59KB	Share
AEF +EYEChange of substantial holder from AEF
07/01/14		82.85KB	Share
EYEEllex Completes Acquisition of Canaloplasty Business
06/01/14		604.29KB	Share
EYEAppendix 3B
03/01/14		308.75KB	Share
EYEAcquistion and Capital Raise
20/12/13	PRICE SENSITIVE	526.96KB	Share
EYETrading Halt
18/12/13	PRICE SENSITIVE	192.33KB	Share
EYEResults of Meeting
28/11/13		284.69KB	Share
EYEEllex AGM Presentation
28/11/13		526.16KB	Share
EYEELX USA SLT Glaucoma Laser Update
12/11/13	PRICE SENSITIVE	69.5KB	Share
AEF +EYEChange in substantial holding from AEF
01/11/13		81.93KB	Share
EYENotice of Annual General Meeting/Proxy Form
24/10/13		377.99KB	Share
EYEAnnual Report to shareholders
24/10/13		825.81KB	Share
EYERelease of Positive Pilot Study Results for 2RT Treatment
14/10/13	PRICE SENSITIVE	77.82KB	Share

REFRESH

First 3 4 5 6 7

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 14.0¢		Change 0.000(0.00%)		Mkt cap ! $39.85M

Open	High	Low	Value	Volume
14.5¢	14.5¢	14.0¢	$740	5.139K

Buyers (Bids)

No.	Vol.	Price($)
5	201617	14.0¢

Sellers (Offers)

Price($)	Vol.	No.
14.5¢	320748	2

View Market Depth

No.	Vol.	Price($)
7	283617	0.140
11	798832	0.135
7	336065	0.130
6	262110	0.125
3	96666	0.120

Price($)	Vol.	No.
0.145	320748	2
0.150	356190	6
0.155	155560	2
0.160	155290	3
0.165	111480	3

Last trade - 12.20pm 12/08/2025 (20 minute delay)

EYE (ASX) Chart

NOVA EYE MEDICAL LIMITED - Announcements

Corporate SpotlightNot Yet Available

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories

Corporate Spotlight
Not Yet Available